Reports & White Papers

A new strategy toolkit to help benefits leaders evaluate solutions to address metabolic health, including sample RFP questions.

A new national survey shines a light on what older adults with type 2 diabetes want from their Medicare Advantage plan.

How do health disparities contribute to higher prevalence and worsening outcomes in type 2 diabetes, and how can we make more equitable care a reality?

The Validation Institute has now awarded Virta three distinct validations for savings, outcomes and comprehensive program.

Is it possible to reverse diabetes? New research says yes. Go behind the scenes of the revolution happening in diabetes care.

Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.

ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.

Guidance on diabetes solutions for employers in a fragmented ecosystem from EHIR, the Employee Health Innovation Roundtable.